HELSINKI, Finland, May 2021. Euformatics and Al Jeel have signed a distribution partnership covering the Kingdom of Saudi Arabia, expanding the reach of the company’s omnomics Suite of NGS software products to hospitals and laboratories as NGS sequencing technology uptake continues to expand in the Middle East.

The agreement follows the selection of Al Jeel as the local distributor of the largest global sequencer provider in the world, Illumina, and the resulting need to complement the instruments and kits in their portfolio with high quality bioinformatics software for the Saudi healthcare sector. The agreement covers the entire Euformatics product portfolio to provide world-leading NGS test validation, quality control and variant interpretation software to hospitals and laboratories in the Kingdom. As the exclusive distributor for Illumina in Saudi Arabia, Al Jeel has the best visibility to local laboratories that are moving into clinical diagnostics using NGS and are thus best positioned to provide an end-to-end solution for these customers.

As part of a renewed strategy for Euformatics to expand its network of global distribution partners, the agreement with Al Jeel comes at an opportune moment. As laboratories are starting to refocus their efforts partially away from doing only PCR testing for SARS-CoV-2 samples, many are now looking to increase their use of NGS techniques for other diagnostic procedures.

Al Jeel Abdul Ghani Marwan Elajou

“We believe that the omnomics Suite is the best offering on the market for our clinical customers. As the NGS market grows in Saudi Arabia and more laboratories see the value of NGS techniques, we are confident that omnomicsQ will ensure that the quality of the generated data is high while omnomicsNGS will help our medical professionals to quickly annotate and report on dangerous variants. We are excited to offer Euformatics’ products to our Illumina customers, and provide a true end-to-end solution for NGS workflows.” says Abdul Ghani Marwan Elajou, Al Jeel General Manager.

Euformatics CEO Tommi Kaasalainen

“We see big potential for our products in Saudi Arabia and are glad we were approached by Al Jeel, which is a respected player in the field and has built impressive operations in the Kingdom. As the only clinical bioinformatics software in Al Jeel’s portfolio we are both humbled and excited to serve their customers to the best of our ability. We will start by training their staff to be specialists with our tools in front of their customers and support their sales team through demos and the setting-up of trials for customers to experience the value of our tools for themselves.” adds Tommi Kaasalainen, Euformatics CEO.

The agreement builds on Euformatics’ previous sales activities in Saudi Arabia, including the recent closing of King Fahad Specialist Hospital in Dammam as a local reference customer.

About Al Jeel:

Al-Jeel Medical Company is the leading healthcare solutions provider in the Kingdom of Saudi Arabia. Over the years, we have partnered with the world’s most renowned healthcare companies that provide the best-in-class solutions & finest technology. For more than five decades, and now with a new visionary & innovative third generation leadership, we have been continuously contributing to the rapidly evolving healthcare market in the Kingdom. Through ongoing and sustainable improvements across all our operational levels, we are capable of providing turnkey solutions that generate significant short-term and long-term value for healthcare providers and their patients.

We are a healthcare enabler firm that offers insightful data, innovative solutions, and cutting-edge technology across 3 main divisions: Dental, Medical, and In-Vitro Diagnostic Solutions. We aim to provide valuable knowledge & actionable insights to various healthcare institutions, so they can become capable of making the right decisions regarding their patients’ health and well-being. Moreover, we are constantly striving to offer revolutionary healthcare solutions & technology to significantly advance the Kingdom’s healthcare ecosystem.

With our TRACE, ISO, and SFDA certifications, we affirm to always place quality as our top priority to contribute better customer service and allow for continuous improvement throughout our entire organization.

For more information, please visit our website

About Euformatics:

Euformatics is a Finnish software company that specialises in high standard bioinformatics tools for genomic data interpretation. Since 2010, Euformatics has been helping medical doctors and molecular genetics laboratories provide better precision medicine for cancer, common or rare disease diagnostics. At present, our core solution is the omnomics Suite which includes omnomicsNGS; for clinical analysis and reporting of patient NGS data, and omnomicsQ; for NGS data quality management.

For more information, please visit our website

Back to news listing